Yes, Iagree. However it is not the patient who decides on the supplier of the valve. The discussion, in conjunction with the cardiologist and surgical team is made with the patient concerning the type of valve to be selected, the supplier of that valve is not.
- Forums
- ASX - By Stock
- Ann: DurAVR First In Human Patient 6 Month Study Follow Up
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

Yes, Iagree. However it is not the patient who decides on the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 200 | 1 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online